Related references
Note: Only part of the references are listed.Assessment of the usefulness of anti-Wb123 antibody for post-elimination surveillance of lymphatic filariasis
Ameyo Monique Dorkenoo et al.
PARASITES & VECTORS (2021)
Single-Dose Triple-Drug Therapy for Wuchereria bancrofti-5-Year Follow-up
Christopher L. King et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Safety and efficacy of co-administered diethylcarbamazine, albendazole and ivermectin during mass drug administration for lymphatic filariasis in Haiti: Results from a two-armed, open-label, cluster-randomized, community study
Christine L. Dubray et al.
PLOS NEGLECTED TROPICAL DISEASES (2020)
Time for a diagnostic sea-change: Rethinking neglected tropical disease diagnostics to achieve elimination
Katherine Gass
PLOS NEGLECTED TROPICAL DISEASES (2020)
Use of Antibody Tools to Provide Serologic Evidence of Elimination of Lymphatic Filariasis in The Gambia
Kimberly Y. Won et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2018)
A Trial of a Triple-Drug Treatment for Lymphatic Filariasis
Christopher L. King et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Efficacy, Safety, and Pharmacokinetics of Coadministered Diethylcarbamazine, Albendazole, and Ivermectin for Treatment of Bancroftian Filariasis
Edward K. Thomsen et al.
CLINICAL INFECTIOUS DISEASES (2016)
Positivity of Antigen Tests Used for Diagnosis of Lymphatic Filariasis in Individuals without Wuchereria bancrofti Infection but with High Loa loa Microfilaremia
Sebastien D. Pion et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2016)
Social stigma towards neglected tropical diseases: a systematic review
Karlijn Hofstraat et al.
INTERNATIONAL HEALTH (2016)
The health and economic benefits of the global programme to eliminate lymphatic filariasis (2000-2014)
Hugo C. Turner et al.
INFECTIOUS DISEASES OF POVERTY (2016)
Cross-Reactivity of Filariais ICT Cards in Areas of Contrasting Endemicity of Loa loa and Mansonella perstans in Cameroon: Implications for Shrinking of the Lymphatic Filariasis Map in the Central African Region
Samuel Wanji et al.
PLOS NEGLECTED TROPICAL DISEASES (2015)
A Comprehensive Assessment of Lymphatic Filariasis in Sri Lanka Six Years after Cessation of Mass Drug Administration
Ramakrishna U. Rao et al.
PLOS NEGLECTED TROPICAL DISEASES (2014)
Progress and Impact of 13 Years of the Global Programme to Eliminate Lymphatic Filariasis on Reducing the Burden of Filarial Disease
K. D. Ramaiah et al.
PLOS NEGLECTED TROPICAL DISEASES (2014)
Longitudinal Monitoring of the Development of Antifilarial Antibodies and Acquisition of Wuchereria bancrofti in a Highly Endemic Area of Haiti
Katy L. Hamlin et al.
PLOS NEGLECTED TROPICAL DISEASES (2012)
A Multicenter Evaluation of Diagnostic Tools to Define Endpoints for Programs to Eliminate Bancroftian Filariasis
Katherine Gass et al.
PLOS NEGLECTED TROPICAL DISEASES (2012)
A multicenter evaluation of a new antibody test kit for lymphatic filariasis employing recombinant Brugia malayi antigen Bm-14
Gary J. Weil et al.
ACTA TROPICA (2011)
Lymphatic filariasis and onchocerciasis
Mark J. Taylor et al.
LANCET (2010)
Diagnostic tools for filariasis elimination programs
Gary J. Weil et al.
TRENDS IN PARASITOLOGY (2007)
Influence of infection with non-filarial helminths on the specificity of serological assays for antifilarial immunoglobulin G4
AE Muck et al.
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2003)
A recombinant antigen-based IgG4 ELISA for the specific and sensitive detection of Brugia malayi infection
N Rahmah et al.
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2001)